Business of Cannabis reports
After his first 100 days as president, Moetai Brotherson announced this week that the project to legalise CBD in Polynesia was ready.
The bill, known as article LP3, establishes an innovative framework for the use and importation of hemp. Article LP3 authorises the Polynesian population to “transport, import, export, hold, offer, transfer, acquire, process and use products containing or derived from hemp seeds”. These products must be “devoid of narcotic properties”, i.e. their THC content must currently be less than 0.3%.
In Polynesia’s tropical climates, however, cannabis plants produce an excess of phytocannabinoids, making it difficult for the local industry to maintain the 0.3% THC threshold set by French standards.
The Polynesian Hemp Syndicate, led by its president Philippe Cathelain, has called for this threshold to be raised to 1%, taking into account local conditions. This recommendation stems from a fact-finding mission by the French National Assembly, which stressed the need for tolerance in overseas territories, as is already the case for Réunion.
The new legislation has three key components. In addition to the legalisation of CBD, the Ministry of Agriculture has drawn up a second text covering the cultivation and processing of hemp. But the most eagerly awaited aspect is the third, concerning medical cannabis. Beyond the anti-stress properties of CBD, health professionals are particularly interested in the pain-relieving potential of THC.
Read more at
https://businessofcannabis.com/polynesia-set-to-legalise-cbd-and-eyes-medical-cannabis-roll-out/
